GLG News by Otolaryngologists (US)

Controlled substances are invaluable in the attempt to control pain for many patients.  Unfortunately, some criminals attempt to obtain these substances for personal gain as they are a valuable commodity on the black market.  Therefore, it is of the utmost importance that industry and...

Private companies have vast resources to underwrite the costs associated with research activities.  It is difficult to ensure that financial assistance and fees paid to researchers do not result in undue influence that may affect the results of research.  To avoid the appearance...

Any publicized adverse events following the injection of filler materials or BOTOX Cosmetic will draw attention to risks inherent in such procedures.  This will likely have a temporary impact on the level of concern and possibly result in a transient decrease in use amongst...

On nights, weekends, and holidays, senior healthcare professionals are rarely found in the hospital.  Problems arise from (1) too few qualified personnel available to address the needs of patients, (2) inability to obtain physician coverage for some specialties, and (3) inability to obtain and/or...

There are interesting findings presented from the phase 3 study.  However, great care should be used in the analysis as it is fairly easy to spin this in a positive direction which may not correlate with a patient's symptomatic improvement.

A cultural shift is alone very unlikely - exercise and proper nutrition has been advocated for decades. Despite this, we have a nationwide epidemic of obesity and accompanying medical problems, including diabetes, hypertension, cardiovascular disease, risk of stroke, sleep apnea. 

Antireflux meds are regular used for treatement of pediatric GERD - specifically for the field of otolaryngology/ENT, this has imprtant application in the management of reflux laryngopharyngitis, refractory sinusitis and tonsillitis, and laryngotracheomalacia exacerbation.

The approval of the pediatric indication for nexium gives a useful alternative to Prevacid.  However, this is already a crowded field where managed care often dictates which PPI is used.  This will likely steal some market share from Prevacid, but will probably be a small addition to Nexium's...

This article highlights the problems facing studies looking at the treatment of acute sinusitis.  Many in big pharma tout excellent efficacy rates for their products treating uncomplicated acute bacterial sinusitis.  In reality, the vast majority of these patients would improve with conservative...

This is the European equivalent of Veramyst.  The control of ocular symptoms is a major marketing push but raises a few questions.  There are concerns regarding cataract formation with the higher potency steroid molecules.  Although low bioavailability is shown, there must be some direct...